Stremitzer, Stefan http://orcid.org/0000-0002-4815-4135
Vermeulen, Peter
Graver, Shannon
Kockx, Mark
Dirix, Luc
Yang, Dongyun
Zhang, Wu
Stift, Judith
Wrba, Friedrich
Gruenberger, Thomas
Lenz, Heinz-Josef
Scherer, Stefan J.
Funding for this research was provided by:
Austrian Science Fund (J3501-B13)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA014089)
Article History
Received: 2 December 2019
Revised: 18 February 2020
Accepted: 3 March 2020
First Online: 24 March 2020
Ethics approval and consent to participate
: The study was approved by the ethics committee of the Medical University of Vienna (1244/2012). The study was performed in accordance with the declaration of Helsinki.
: The data sets generated and/or analysed during the current study are not publicly available due to it containing patients’ personal data, but anonymised data are available from the corresponding author on reasonable request.
: T.G. is member of the advisory boards of Roche, Merck-Serono and Sanofi-Aventis. H.-J.L. is member of the advisory board of Genentech, Merck KG, Bayer and BMS. All remaining authors have declared no conflict of interest.
: S.S. is a recipient of an Erwin Schrödinger fellowship of the Austrian Science Fund (J3501-B13). H.-J.L. receives financial support from the National Institute of Health (P30CA014089) and the Gloria Borges Wunderglo Foundation.